DEGS2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-30931
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Synthetic peptide derived from human DEGS2 protein.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for DEGS2 Antibody
Western Blot: DEGS2 Antibody [NBP3-30931] -
Western Blot: DEGS2 Antibody [NBP3-30931] - Western blot using antigen immunoaffinity purified anti DEGS2 antibody (Cat. No. NBP3-30931) on human kidney cell lysate. Lysate used at 15 ug/lane. Antibody used at 1:400 dilution. Secondary antibody, mouse anti-rabbit HRP , used at 1:50k dilution. Visualized using Pierce West Femto substrate system. Exposure for 5 minutesApplications for DEGS2 Antibody
Application
Recommended Usage
Western Blot
: 1-5 ug/ml
Application Notes
.
Formulation, Preparation, and Storage
Purification
Ammonium sulfate precipitation
Formulation
Phosphate buffered saline
Preservative
0.08% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: DEGS2
Alternate Names
C14orf66, chromosome 14 open reading frame 66, Degenerative spermatocyte homolog 2, degenerative spermatocyte homolog 2, lipid desaturase (Drosophila), DES2sphingolipid delta(4)-desaturase/C4-hydroxylase DES2, EC 1.14, FADS8, sphingolipid C4-hydroxylase/delta 4-desaturase, sphingolipid delta 4 desaturase/C-4 hydroxylase
Gene Symbol
DEGS2
Additional DEGS2 Products
Product Specific Notices for DEGS2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...